$XMTR

Xometry director Randolph Altschuler sells $1.63 million in shares

Xometry director Randolph Altschuler sold $1.63M in shares on Oct 1-2, 2026, via pre-planned trades. XMTR stock is near its 52-week high, up 99% YoY, but shows negative free cash flow. Q2 2026 earnings beat estimates, with revenue up 41% YoY. Analysts raised price targets to $120 with Buy ratings.

Original reporting
Published Oct 3, 2026, 1:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 3, 2026, 8:50 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$XMTR
Bearish
medium confidence
Mentioned
$XMTR
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$XMTRBearishLow
01

Why it matters

The insider sales occur shortly after the earnings beat, providing fresh data for traders.

02

Market read

New Form 4 filing adds modest negative pressure to XMTR after a strong earnings beat.

03

What to watch

Recent strong earnings and analyst upgrades could offset the sell‑off.

Relevance 5/10Novelty 5/10Timing: post‑market today

Background

XMTR recently reported Q2 2026 earnings beating expectations, with analysts raising price targets to $120.

Company-level read

Ticker impact

$XMTRBearishMedium confidence
Context

Director Randolph Altschuler and his spouse sold $1.63 M of XMTR Class A shares via 10b5‑1 plans on Oct 1‑2, a new Form 4 filing.

Expected impact

likely pressure as investors price in the insider sell-off

Evidence & confidence

The sale size is modest but recent; market often reacts negatively to insider disposals.

Market effects

Minimal impact on the custom manufacturing marketplace sector.

U.S. market only; no broader regional effect.

Low; the filing is company‑specific.

Counterpoint

The sale may be routine tax planning rather than a negative signal.

Key entities

  • Randolph Altschuler

    XMTR director who sold shares via 10b5‑1 plan.

Related articles

$XMTRMed

Is Xometry Stock Still a Buy After a 144% Six-Month Run?

Xometry (XMTR) stock has surged 144% in six months, driven by strong Q2 earnings and a Siemens partnership. Q2 revenue was $229.28M, up 41% YoY, beating estimates. Analysts have raised targets to $110, 14% above current price. Insiders have sold $3.46M in stock since July.

$XMTRMedAI 8/10

Six Montgomery County companies attract more than $566 million in capital investment – WTOP News

Six Montgomery County companies raised over $566 million in Q3. Forbright (Nasdaq) completed an IPO, raising $142.2 million. Xometry (Nasdaq) announced a $225 million secondary offering. RegenxBio (Nasdaq) raised $90.04 million in a public offering. Georgiamune secured $92.69 million in venture funding. Arculus Solutions raised $1.95 million in Seed-1 funding. Jesse & Ben raised $15 million in Series A funding.

$XMTRHighAI 9/10

Xometry (XMTR) Q2 2026 Earnings Call Transcript

Xometry (XMTR) reported Q2 2026 revenue of $229.3 million, up 41% year over year, with marketplace revenue of $215.4 million (+45%). Adjusted EBITDA was $14.1 million, and non-GAAP net income was $9.9 million. The company raised Q3 2026 revenue guidance to $234 million to $236 million and full-year 2026 revenue growth to 33% to 34%.

$XMTRMed

Xometry, Inc. Q2 2026 Earnings Call Summary

Xometry, Inc. reported Q2 2026 results and said revenue growth accelerated for a fourth straight quarter, driven by a product-led shift toward an AI ecosystem. It cited improved CNC cost prediction accuracy (+~15%), record 175 net new enterprise accounts over $50,000, and reduced ad spend to 3.4% of revenue. Full-year 2026 revenue growth guidance raised to 33%-34% and marketplace gross margin target 35%-40%. Cash was $517M after a $248M follow-on and $50M Siemens investment.